Thursday, October 8, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 28, 2026

AT&T (T) Q4 2025 Earnings Call Transcript

View original at finance.yahoo.com
AT&T (T) Q4 2025 Earnings Call Transcript Image source: The Motley Fool. DATE Wednesday, January 28, 2026 at 8:30 a.m…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Current federal policy is the most supportive of market-based network investment in CEO's career

    80% confidence
  • There are continued opportunities for cost optimization

    80% confidence
  • Bad debt increase is driven by higher equipment sales and service revenue growth, not payment pattern changes

    80% confidence
  • This is a structural realignment of the industry, ultimately going to be an industry of converged providers

    80% confidence
  • Advanced home internet will grow 20%+ organic annual growth, with 30%+ reported growth in 2026 including Lumen

    80% confidence
  • 2028 target for adjusted EPS is double-digit 3-year CAGR

    80% confidence
  • Wireless service revenue will grow 2-3% annually through 2026-2028

    80% confidence
  • Business service revenue will have low single-digit CAGR through 2028

    80% confidence
  • AT&T will lead the industry in advanced connectivity service revenue and adjusted EBITDA by end of this decade

    80% confidence
  • AI revolution will increase demand for dense fiber and symmetrical connectivity

    80% confidence
  • 2028 target for adjusted EBITDA growth is 5%+ annually

    80% confidence
  • Total shareholder returns 2026-2028 will be $45B+ representing approximately 30% of market cap and 75%+ of expected free cash flow

    80% confidence
  • Adjusted EPS guidance for 2026 is $2.25-$2.35 range with approximately $0.05 dilution from acquisitions

    80% confidence
  • Free cash flow guidance for 2026 is $18B+

    80% confidence

Data points we hold from this source

AT&T Inc. · advanced connectivity ebitda percentage95 percent
AT&T Inc. · fiber convergence rate42 percent
AT&T Inc. · cost savings1 billion_USD
AT&T Inc. · shareholder returns12 billion_USD
AT&T Inc. · buybacks4 billion_USD
AT&T Inc. · postpaid phone net adds1.5 millions
AT&T Inc. · spectrum per cell site300 MHz
AT&T Inc. · market share premium in fiber areas10 percentage_points
AT&T Inc. · margin expansion20 basis_points
AT&T Inc. · net debt to ebitda2.53 ratio
AT&T Inc. · pension contribution1.15 billion_USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,362 source documents archived
Query this data → isubstrate.com